P. Boros

发表

Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice.

F. Ginhoux, F. Tacke, M. Merad, 2010, The Journal of clinical investigation.

Regulatory immune cells and functions in autoimmunity and transplantation immunology.

B. Nakken, P. Szodoray, P. Boros, 2017, Autoimmunity reviews.

New Cellular and Molecular Immune Pathways in Ischemia/Reperfusion Injury

P. Boros, J. Bromberg, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Myeloid-derived suppressor cells: natural regulators for transplant tolerance.

J. Ochando, P. Boros, Shu-Hsia Chen, 2010, Human immunology.

The efficacy of prophylactic interferon alfa‐2b in preventing recurrent hepatitis C after liver transplantation

Charles M. Miller, C. Bodian, F. Klion, 1998, Hepatology.

Inhibiting Inflammation with Myeloid Cell‐Specific Nanobiologics Promotes Organ Transplant Acceptance

F. Ginhoux, M. Netea, Z. Fayad, 2018, Immunity.

Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels.

T. Fishbein, P. Boros, M. Schwartz, 2001, Mediators of inflammation.

Th1/Th2 cytokines and ICAM-1 levels post-liver transplant do not predict early rejection.

P. Boros, M. Schwartz, S. Emre, 2000, Mediators of inflammation.

Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.

P. Boros, M. Schwartz, S. Roayaie, 2000, Mediators of inflammation.

Immunogenetic and immunologic studies of differentiated thyroid cancer

P. Surányi, N. Farid, P. Boros, 1989, Cancer.

DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.

James A. Hutchinson, F. Ginhoux, M. Merad, 2015, Immunity.

Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat.

J. Megyesi, P. Boros, L. Wang, 2001, Transplantation.

Hepatocyte growth factor: a multifunctional cytokine

P. Boros, C. Miller, 1995, The Lancet.

Alloantigen-Specific Foxp3+ Regulatory T Peripheral Development of Lymph Node Occupancy Is Required for the

S. Lira, J. Ochando, Yu Yang, 2013 .

Lymph Node Occupancy Is Required for the Peripheral Development of Alloantigen-Specific Foxp3+ Regulatory T Cells1

S. Lira, A. Garin, J. Ochando, 2005, The Journal of Immunology.

T Foxp3 Alloantigen-Specific Peripheral Development of Lymph Node Occupancy Is Required for the

S. Lira, A. Garin, J. Ochando, 2005 .

Orthotopic tracheal transplantation in the murine model.

E. Genden, L. Mayer, P. Boros, 2002, Transplantation.

DC-SIGN + Macrophages C ontrol the Induction of Transplantation Tolerance Graphical

James A. Hutchinson, F. Ginhoux, M. Merad, 2015 .

Immunotherapy with myeloid cells for tolerance induction

J. Ochando, P. Boros, J. Bromberg, 2010, Current opinion in organ transplantation.

Successful tolerance induction under CD40 ligation in a rodent small bowel transplant model: first report of a study with the novel antibody AH.F5

Charles M. Miller, T. Fishbein, P. Boros, 2002, Transplantation.

Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts

F. Tacke, R. Jessberger, G. Trinchieri, 2006, Nature Immunology.

L-Selectin-Dependent Lymphoid Occupancy Is Required to Induce Alloantigen-Specific Tolerance1

P. Boros, J. Bromberg, Jianhua Liu, 2002, The Journal of Immunology.

Assessment of liver allograft function by hyaluronic acid and endothelin levels.

P. Boros, M. Schwartz, S. Emre, 1997, The Journal of surgical research.

THE POLYMORPHIC HUMAN TLX‐B/CD46/MCP SYSTEM AND ITS IMPLICATIONS IN TRANSPLANTATION AND REPRODUCTION

V. Fülöp, G. Sármay, P. Boros, 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Circulating Fcγ receptor-specific autoantibodies in localized and systemic scleroderma

P. Boros, J. Unkeless, R. Fleischmajer, 1995 .

Increased apoptosis is specific for acute rejection in rat small bowel transplant.

T. Fishbein, Yansui Li, P. Boros, 2004, The Journal of surgical research.

IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation

C. Bona, P. Boros, J. Unkeless, 1991, The Journal of experimental medicine.

Differential effect of hepatocyte growth factor and tumor growth factor-beta on early release of vascular endothelial growth factor from HepG2 cells: possible implications in post-transplant liver regeneration.

P. Boros, C. Miller, E. Granot, 2001, Transplantation proceedings.

Organ transplantation in rodents: novel applications of long-established methods.

Yansui Li, P. Boros, J. Bromberg, 2007, Transplant immunology.

Donor des‐gamma‐carboxy prothrombin positivity is a risk factor for poor early graft function in liver transplantation

Charles M. Miller, P. Boros, M. Schwartz, 1998 .

Donor des-gamma-carboxy prothrombin positivity is a risk factor for poor early graft function in liver transplantation

P. Boros, M. Schwartz, S. Emre, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Differential in vivo recovery of sinusoidal endothelial cells, hepatocytes, and Kupffer cells after cold preservation and liver transplantation in rats.

J. Machac, Z. Zhang, P. Boros, 1998, Transplantation.

De novo autoimmunity after organ transplantation: targets and possible pathways.

P. Boros, J. Bromberg, 2008, Human immunology.

Myeloid derived suppressor cells and autoimmunity.

J. Ochando, P. Boros, M. Zeher, 2016, Human immunology.

Change in expression of Fc gamma RIII (CD16) on neutrophils from human immunodeficiency virus-infected individuals.

P. Boros, J. Unkeless, G. Bekesi, 1990, Clinical immunology and immunopathology.

ToleranceIs Required to Induce Alloantigen-Specific L-Selectin-Dependent Lymphoid Occupancy

P. Boros, J. Bromberg, Jianhua Liu, 2002 .

High dose intravenous immunoglobulin treatment: Mechanisms of action

P. Boros, J. Bromberg, G. Gondolesi, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Pretransplant Immunomodulation of Highly Sensitized Small Bowel Transplant Candidates with Intravenous Immune Globulin

T. Schiano, G. Rodríguez-Laiz, P. Boros, 2006, Transplantation.

Effluent levels of thrombomodulin predict early graft function in clinical liver transplantation.

P. Boros, M. Schwartz, S. Emre, 2008, Liver.

Assessment of damage and recovery of sinusoidal endothelial cell function by in vivo hyaluronic acid uptake in cold-preserved and transplanted rat livers.

P. Boros, L. Wang, C. Miller, 1996, Transplantation.

The innate immune response to allotransplants: mechanisms and therapeutic potentials

J. Ochando, P. Boros, Stefan Jordan, 2019, Cellular & Molecular Immunology.

Tolerogenic dendritic cells in organ transplantation

A. Thomson, J. Ochando, P. Boros, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops.

L. Mayer, P. Boros, T. Moran, 2005, The Journal of clinical investigation.

Gene transfer methods for transplantation.

P. Boros, J. Bromberg, Y. Ding, 2002, Methods in enzymology.

IgM Anti-FcyR Autoantibodies Trigger Neutrophil Degranulation

C. Bona, P. Boros, J. Unkeless, 2003 .

Differential contribution of graft and recipient to perioperative TNF-alpha, IL-1 beta, IL-6 and IL-8 levels and correlation with early graft function in clinical liver transplantation.

P. Boros, M. Schwartz, S. Emre, 1997, Clinical transplantation.

Fc receptor-mediated signal transduction

P. Boros, J. Unkeless, Zhenhai Shen, 2005, Journal of Clinical Immunology.

Value of caval effluent in predicting early graft function after orthotopic liver transplantation.

P. Boros, M. Schwartz, S. Emre, 1997, Transplantation proceedings.

Dibutyryl cAMP reduces nonparenchymal cell damage during cold preservation of rat livers.

P. Boros, M. Schwartz, D. Podkameni, 1995, The Journal of surgical research.

Orthotopic small bowel transplantation in mice.

T. Fishbein, P. Boros, J. Bromberg, 2005, Transplantation.

Correlation between von Willebrand factor levels and early graft function in clinical liver transplantation

P. Boros, M. Schwartz, S. Emre, 1999, Clinical transplantation.

Autoimmune mice make anti-Fc gamma receptor antibodies

C. Bona, P. Boros, J. Unkeless, 1990, The Journal of experimental medicine.

Human FOXP3+ Regulatory T Cells in Transplantation

P. Boros, J. Bromberg, Jonathan S. Bromberg, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The innate immune response to allotransplants: mechanisms and therapeutic potentials

J. Ochando, P. Boros, Stefan Jordan, 2019, Cellular & Molecular Immunology.

Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease.

P. Boros, J. Unkeless, J. Odin, 1994, Journal of Immunology.

Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance

F. Ginhoux, V. Pothula, J. Ochando, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Combination of Electroporation and DNA/Dendrimer Complexes Enhances Gene Transfer into Murine Cardiac Transplants

J. Baker, A. Bielinska, P. Boros, 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

DNA/dendrimer complexes mediate gene transfer into murine cardiac transplants ex vivo.

J. Baker, A. Bielinska, P. Boros, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Expression of GMP-140 (P-selectin) correlates with graft viability in cold-preserved rat livers.

P. Boros, L. Wang, C. Miller, 2000, Transplantation.

Autoantibodies directed against different classes of Fc gamma R are found in sera of autoimmune patients.

C. Bona, H. Spiera, P. Boros, 1993, Journal of immunology.

Serum cytokine and anti-FcγR autoantibody measurements in patients with systemic sclerosis

L. Czirják, P. Boros, J. Unkeless, 1996 .

Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.

P. Boros, J. Unkeless, R. Fleischmajer, 1995, Journal of the American Academy of Dermatology.

Hyperosmolarity associated with diabetes insipidus alters hepatocyte structure and function but not survival after orthotopic liver transplantation in rats.

P. Boros, L. Wang, C. Miller, 1998, Transplantation.